Administrative Core
行政核心
基本信息
- 批准号:10622124
- 负责人:
- 金额:$ 11.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-23 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAllograft ToleranceBibliographyBiometryClinical TrialsCommunicationConsultationsData AnalysesFloorFundingGeneral HospitalsGoalsGrantHospitalsHuman ResourcesInstitutionJointsManuscriptsMassachusettsMedicinePreparationProgress ReportsPublicationsReportingResearchResearch DesignResearch PersonnelResourcesSample SizeScienceSolidStructureUnited States National Institutes of HealthWorkanimal datadata exchangedesignexperiencelung allograftmedical schoolsmeetingsnovel strategiesprofessorprogramssymposiumtransplant centers
项目摘要
CORE SUMMARY / ABSTRACT
The Administrative Core will manage the budgetary, administrative, and communication aspects of this U19. The Core
will be responsible for coordinating meetings and interactions among investigators, transmitting data, communicating
with NIH program personnel, preparing publications, and maintaining a bibliography describing work performed, and
all relative financial matters. The PI has solid expertise in managing and administering large programs from his
experiences as Director of the Massachusetts General Hospital Transplant Center and Center for Transplantation
Sciences, leading previous NIH-funded P01/U19 grants and overseeing NIH-sponsored clinical trials. The Program
Manager will act as a liaison with the hospital’s financial office, office of research affairs, and materials management.
The Administrative Core also includes a program statistician, who is available for consultation on study design,
calculation of sample size, and for analysis of data from the animal studies.
核心摘要/摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joren C Madsen其他文献
Effect of Recipient Hepatitis C Status on the Outcome of Deceased Donor Kidney Transplantation
受者丙型肝炎状况对已故供体肾移植结果的影响
- DOI:
10.1016/j.jamcollsurg.2019.12.039 - 发表时间:
2020 - 期刊:
- 影响因子:5.2
- 作者:
Qing Yuan;Shanjuan Hong;Andric Perez-Ortiz;Eve Roth;David C Chang;Joren C Madsen;Nahel Elias - 通讯作者:
Nahel Elias
Effect of Recipient Hepatitis C Status on the Outcome of Deceased Donor Kidney Transplantation
- DOI:
https://doi.org/10.1016/j.jamcollsurg.2019.12.039 - 发表时间:
2020 - 期刊:
- 影响因子:
- 作者:
Qing Yuan;Shanjuan Hong;Andric Perez-Ortiz;Eve Roth;David C Chang;Joren C Madsen;Nahel Elias - 通讯作者:
Nahel Elias
Joren C Madsen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joren C Madsen', 18)}}的其他基金
Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primates
使用经过训练的免疫抑制纳米生物制剂来实现非人类灵长类动物同种异体心脏移植的耐受性
- 批准号:
10642598 - 财政年份:2023
- 资助金额:
$ 11.93万 - 项目类别:
Infrastructure and Opportunities Fund Management Core
基础设施和机会基金管理核心
- 批准号:
10622126 - 财政年份:2023
- 资助金额:
$ 11.93万 - 项目类别:
Novel Approaches to Inducing Lung Allograft Tolerance in NHPs
诱导 NHP 肺同种异体移植耐受的新方法
- 批准号:
10622123 - 财政年份:2023
- 资助金额:
$ 11.93万 - 项目类别:
Project 1: Next Generation Mixed Chimerism Strategies to Induce Lung Allograft Tolerance in NHPs
项目 1:诱导 NHP 肺同种异体移植耐受的下一代混合嵌合策略
- 批准号:
10622127 - 财政年份:2023
- 资助金额:
$ 11.93万 - 项目类别:
Project 1: Augmenting Regulatory Mechanisms in Protocols of Transient Mixed Chimerism
项目 1:增强瞬时混合嵌合方案中的监管机制
- 批准号:
10457400 - 财政年份:2021
- 资助金额:
$ 11.93万 - 项目类别:
New Approaches to Inducing Cardiac Allograft Tolerance
诱导心脏同种异体移植耐受的新方法
- 批准号:
10673071 - 财政年份:2021
- 资助金额:
$ 11.93万 - 项目类别:
Project 1: Augmenting Regulatory Mechanisms in Protocols of Transient Mixed Chimerism
项目 1:增强瞬时混合嵌合方案中的监管机制
- 批准号:
10673076 - 财政年份:2021
- 资助金额:
$ 11.93万 - 项目类别:
New Approaches to Inducing Cardiac Allograft Tolerance
诱导心脏同种异体移植耐受的新方法
- 批准号:
10457397 - 财政年份:2021
- 资助金额:
$ 11.93万 - 项目类别:
相似海外基金
Targeting innate immunity for induction of robust renal allograft tolerance
针对先天免疫诱导强大的肾同种异体移植耐受
- 批准号:
10622050 - 财政年份:2023
- 资助金额:
$ 11.93万 - 项目类别:
Novel Approaches to Inducing Lung Allograft Tolerance in NHPs
诱导 NHP 肺同种异体移植耐受的新方法
- 批准号:
10622123 - 财政年份:2023
- 资助金额:
$ 11.93万 - 项目类别:
Project 1: Next Generation Mixed Chimerism Strategies to Induce Lung Allograft Tolerance in NHPs
项目 1:诱导 NHP 肺同种异体移植耐受的下一代混合嵌合策略
- 批准号:
10622127 - 财政年份:2023
- 资助金额:
$ 11.93万 - 项目类别:
Bcl-2 and Mcl-1 inhibition for induction of hematopoietic chimerism and renal allograft tolerance without myelosuppression in nonhuman primates
在非人灵长类动物中抑制 Bcl-2 和 Mcl-1 可诱导造血嵌合和肾同种异体移植耐受,而无需骨髓抑制
- 批准号:
10634698 - 财政年份:2022
- 资助金额:
$ 11.93万 - 项目类别:
Project 3: Enhanced Costimulation Blockade to Achieve Clinically Relevant Heart Allograft Tolerance
项目 3:增强共刺激阻断以实现临床相关的同种异体移植心脏耐受性
- 批准号:
10457402 - 财政年份:2021
- 资助金额:
$ 11.93万 - 项目类别:
New Approaches to Inducing Cardiac Allograft Tolerance
诱导心脏同种异体移植耐受的新方法
- 批准号:
10673071 - 财政年份:2021
- 资助金额:
$ 11.93万 - 项目类别:
New Approaches to Inducing Cardiac Allograft Tolerance
诱导心脏同种异体移植耐受的新方法
- 批准号:
10457397 - 财政年份:2021
- 资助金额:
$ 11.93万 - 项目类别:
New Approaches to Inducing Cardiac Allograft Tolerance
诱导心脏同种异体移植耐受的新方法
- 批准号:
10270357 - 财政年份:2021
- 资助金额:
$ 11.93万 - 项目类别:
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
项目 2:用于心脏同种异体移植耐受的下一代混合嵌合诱导
- 批准号:
10270361 - 财政年份:2021
- 资助金额:
$ 11.93万 - 项目类别:
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
项目 2:用于心脏同种异体移植耐受的下一代混合嵌合诱导
- 批准号:
10457401 - 财政年份:2021
- 资助金额:
$ 11.93万 - 项目类别:














{{item.name}}会员




